Boston Scientific Announces Conference Call Discussing Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Medifast launches Trilivy, replacing its Optavia brand
- Adobe has received a takeover approach by a Big Tech company - Betaville
Boston Scientific (BSX) PT Raised to $48 at Morgan Stanley Following Healthcare Conference
October 2, 2018 7:31 AM EDTMorgan Stanley analyst David Lewis raised the price target on Boston Scientific (NYSE: BSX) to $48.00 (from $38.00) while maintaining a Overweight rating following the Morgan Stanley Healthcare Conference. Investors were concerned 9 deals for $1.6bn year-to-date suggested a weakening core business, but Lewis believes the... More
